Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niggli

Showing results (471-480 of 516) with videos related to

Pageof 52
Sort By:
Pediatric Blood & Cancer|April 20, 2022
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adultsMonika Sparber-Sauer, Andrea Ferrari, Daniel Kosztyla, et al.
Pediatric Blood & Cancer|June 5, 2021
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)Ewa Koscielniak, Monika Sparber-Sauer, Monika Scheer, et al.
Pediatric Blood & Cancer|December 10, 2019
Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registryMonika Sparber-Sauer, Ewa Koscielniak, Christian Vokuhl, et al.
Pediatric Blood & Cancer|September 30, 2014
Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcomaTobias M Dantonello, Monika Stark, Beate Timmermann, et al.
Klinische Padiatrie|October 11, 2017
Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP)Sonja Offenmueller, Ulrike Leiter, Benedikt Bernbeck, et al.
Blood|December 21, 2023
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trialSteven W Pipe, Peter Collins, Christophe Dhalluin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcomaTobias M Dantonello, Christoph Int-Veen, Peter Winkler, et al.
Pediatric Blood & Cancer|November 19, 2019
Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Scheer, Christian Vokuhl, Iris Veit-Friedrich, et al.
The British Journal of Nutrition|June 27, 2014
Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analysesMarcin Barański, Dominika Srednicka-Tober, Nikolaos Volakakis, et al.
Hemasphere|June 5, 2023
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study ProtocolCarmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, et al.
Pageof 52

Showing results (471-480 of 516) with videos related to

Sort By:
Pageof 52
Pediatric Blood & Cancer|April 20, 2022
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adultsMonika Sparber-Sauer, Andrea Ferrari, Daniel Kosztyla, et al.
Pediatric Blood & Cancer|June 5, 2021
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS)Ewa Koscielniak, Monika Sparber-Sauer, Monika Scheer, et al.
Pediatric Blood & Cancer|December 10, 2019
Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registryMonika Sparber-Sauer, Ewa Koscielniak, Christian Vokuhl, et al.
Pediatric Blood & Cancer|September 30, 2014
Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcomaTobias M Dantonello, Monika Stark, Beate Timmermann, et al.
Klinische Padiatrie|October 11, 2017
Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP)Sonja Offenmueller, Ulrike Leiter, Benedikt Bernbeck, et al.
Blood|December 21, 2023
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trialSteven W Pipe, Peter Collins, Christophe Dhalluin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcomaTobias M Dantonello, Christoph Int-Veen, Peter Winkler, et al.
Pediatric Blood & Cancer|November 19, 2019
Low-grade fibromyxoid sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Scheer, Christian Vokuhl, Iris Veit-Friedrich, et al.
The British Journal of Nutrition|June 27, 2014
Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analysesMarcin Barański, Dominika Srednicka-Tober, Nikolaos Volakakis, et al.
Hemasphere|June 5, 2023
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study ProtocolCarmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, et al.
Pageof 52